Combination of CCR4 Inhibitor C‐021 or TGFβR1 Inhibitor Galunisertib With Anti‐PD‐L1 Hinders SOX12‐Mediated HCC Progression and Metastasis. This evidence concerns the gene CD274 and hepatocellular carcinoma.